Page
%P
-
Article
Open AccessDynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42
A reliable blood-based assay is required to properly diagnose and monitor Alzheimer’s disease (AD). Many attempts have been made to develop such a diagnostic tool by measuring amyloid-β oligomers (AβOs) in the...
-
Article
Open AccessOligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
Soluble amyloid-β (Aβ) oligomers are the major toxic substances associated with the pathology of Alzheimer’s disease (AD). The ability to measure Aβ oligomer levels in the blood would provide simple and minima...
